SC
LH icon

Solstein Capital’s Labcorp LH Stock Holding History

Solstein Capital’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-55
Closed -$11K – 325
2022
Q2 		$11K Hold
55
– – 0.01% 252
2022
Q1 		$12K Hold
55
– – 0.01% 281
2021
Q4 		$15K Hold
55
– – 0.01% 292
2021
Q3 		$13K Hold
55
– – 0.01% 330
2021
Q2 		$13K Hold
55
– – 0.02% 308
2021
Q1 		$12K Buy
+55
New +$11K 0.02% 275
2020
Q4 		– Sell
-55
Closed -$9K – 152
2020
Q3 		$9K Hold
55
– – 0.02% 195
2020
Q2 		$8K Sell
55
-8
-13% -$1.11K 0.02% 197
2020
Q1 		$7K Buy
63
+8
+15% +$1.15K 0.03% 205
2019
Q4 		$8K Buy
+55
New +$7.94K 0.02% 288

Other funds holding LH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Solstein Capital's LH Position: Q3 2022 in Review

Solstein Capital sold out of Labcorp (LH) in Q3 2022, closing a stake of 55 shares — an estimated $11K sold.

Solstein Capital first reported a position in LH in Q4 2019 and held it in 10 quarters. The position peaked at $15K in Q4 2021. 936 funds tracked by Wall St. Rank hold LH as of Q3 2022.

  • Solstein Capital reported no remaining Labcorp position as of Q3 2022 after selling out during the quarter.
  • Solstein Capital sold 55 Labcorp shares in Q3 2022, an estimated $11K.
  • Solstein Capital first reported a position in Labcorp in Q4 2019 and held it in 10 quarters.
  • Solstein Capital's Labcorp position peaked at $15K in Q4 2021.
  • 936 funds tracked by Wall St. Rank held Labcorp as of Q3 2022.

Based on Solstein Capital's 13F filing for Q3 2022, filed 1 Nov 2022.